Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.21.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Summary of Outstanding Stock Warrants

A summary of the status of the Company’s outstanding stock warrants and changes during the three months ended March 31, 2021 is as follows :

 

    Number of Warrants     Weighted Average
Exercise Price
    Weighted Average Remaining Contractual Life
(in years)
 
Outstanding as of December 31, 2020     287,656     $ 12.64       2.7  
Issued     375,000       25.00       4.8  
Expired     -       -       -  
Exercised     (213,866 )     7.49       3.1  
Outstanding as of March 31, 2021     448,790     $ 25.42       4.1  
Warrants exercisable as of March 31, 2021     448,790     $ 25.42       4.1  
Summary of Stock Options

A summary of the stock options as of March 31, 2021 and changes during the period are presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Weighted Average Remaining Contractual Life
(in years)
 
Outstanding as of December 31, 2020     106,120     $ 44.32       4.28  
Exercised     (25,000 )     2.04       -  
Outstanding as of March 31, 2021     81,120     $ 57.35       4.25  
Options vested and expected to vest as of March 31, 2021     81,120     $ 57.35       4.25  
Options vested and exercisable as of March 31, 2021     81,120     $ 57.35       4.25  
                         
The aggregate intrinsic value of options outstanding and exercisable at March 31, 2021 was           $ 701,466          
Summary of Restricted Stock Award Activity

A summary of the restricted stock award activity for the three months ended March 31, 2021 as follows :

 

    Number of Units     Weighted
Average Grant
Date Fair Value
 
Nonvested at December 31, 2020     566,279     $ 0.43  
Granted     4,999,999     $ 10.44  
Vested     (5,289,594 )   $ 9.37  
Nonvested at March 31, 2021     276,684     $ 10.44